454-29-5(DL-Homocysteine) Product Description

HOMOCYSTEINE, DL-(P) DL-Homocysteine,2-Amino-4-mercaptobutyric acid DL-HoMocystein (+-)-homocysteine dl-2-amino-4-mercaptobutyricacid usafb-12 2-AMINO-4-MERCAPTOBUTYRIC ACID 2-AMINO-4-MERCAPTOBUYRIC ACID 2-amino-4-sulfanylbutanoic acid HOMOCYSTEINE, DL-(RG) TOTALHOMOCYSTEINE H-DL-Hcys-OH DL-HOMOCYSTEINE HOMOCYSTEINE, DL- DL-Homocysteine 2-Amino-4-mercaptobuyric acid DL-Homocysteine 503-33-6/454-29-5 DL-Homocysteine> DL-Homocysteine USP/EP/BP Aminocaproic Acid Impurity 14 DL-Homocysteine 454-29-5 NS 2212 NSC 2212 NSC-2212 Butyric acid, 2-amino-4-mercapto-, DL- (9CI) (2R)-2-ammonio-4-mercaptobutanoate DL-Homocysteine,95% 454-29-5 503-33-6 HSC2H4CHNH2COOH HSCH2CH2CHNH2COOH Increased plasma homocysteine is a risk factor for coronary heart disease and carcinogenesis; may be a marker for tumor cell growth. AMINE Cancer Research BioChemical Homo-Amino Acids Specialty Synthesis Unnatural Amino Acid Derivatives Tumor Promotors Tumor Growth Regulation Peptide Synthesis Amino Acids Amino Acids